Authors: Pei Han, Wu Zhong, Yin Xiangke, Song Zongming, Gao Shaohui DOI: 10.3760/cma.j.cn115989-20260210-00073 Published: 2026 -04 -10 Citation Pei Han, Wu Zhong, Yin Xiangke, et al. Effect of serial intravitreal injections with anti-VEGF on the ocular surface for patients with diabetes[J]. Chin J Exp Ophthalmol, 2026, 44(4):369-373. DOI: 10.3760/cma.j.cn115989-20260210-00073. ABSTRACT [Download […]
Tag: Intravitreal injections
Retinal and corneal toxicity analysis of different intraocular injection methods of foscarnet sodium in rabbit eyes
Authors: Zhao Yinghan, Sun Binjia, Lu Qing, Li Chendi, Yu Ting, Hong Jing, Peng Rongmei DOI: 10.3760/cma.j.cn115989-20240302-00058 Published: 2025 -08 -10 Citation Zhao Yinghan, Sun Binjia, Lu Qing, et al. Retinal and corneal toxicity analysis of different intraocular injection methods of foscarnet sodium in rabbit eyes[J]. Chin J Exp Ophthalmol, 2025, 43(8):713-721. DOI: 10.3760/cma.j.cn115989-20240302-00058. ABSTRACT […]
Advances in intravitreal ganciclovir treatment of cytomegalovirus retinitis after hematopoietic stem cell transplantation
Authors: Chen Weibin, Zhao Mingwei, Miao Heng DOI: 10.3760/cma.j.cn115989-20220116-00020 Published 2023-10-10 Cite as Chin J Exp Ophthalmol, 2023, 41(10): 1033-1037. Abstract 【Download PDF】 【Read Full Text】 Hematopoietic stem cell transplantation (HSCT) brings the possibility to prolong survival for patients with different types of […]
Paying close attention to the therapeutic effect of brolucizumab on polypoidal choroidal vasculopathy and its clinical application
Authors: Liu Jingyao, Liu Boshi, Li Xiaorong DOI: 10.3760/cma.j.cn115989-20230315-00087 Published 2023-07-10 Cite as Chin J Exp Ophthalmol, 2023, 41(7): 617-622. Abstract [Download PDF] [Read Full Text] Polypoidal choroidal vasculopathy (PCV) occurs in the middle-aged and elderly population and is characterized by abnormal […]
Progress in controlled ocular anti-VEGF drug release delivery system
Authors: Yang Songyang, Zhang Mingliang, Li Xiaorong DOI: 10.3760/cma.j.cn115989-20200612-00424 Published 2023-06-10 Cite as Chin J Exp Ophthalmol, 2023, 41(6): 612-616. Abstract [Download PDF] [Read Full Text] Neovascularization is the hallmark of many fundus diseases, including diabetic retinopathy, retinal vein occlusion and […]
Early hypotony after the intravitreal injection of anti-vascular endothelial growth factor and its risk factors
Authors: Gao Shaohui, Pei Han, Li Mengdi, Wu Zhong, Zhao Zhaoxia DOI: 10.3760/cma.j.cn115989-20220830-00405 Published 2023-03-10 Cite as Chin J Exp Ophthalmol, 2023, 41(3): 276-281. Abstract [Download PDF] [Read Full Text] Objective To analyze the occurrence of early hypotony after the intravitreal injection […]
Comparison of efficacy between intravitreal injection of conbercept with and without macular photocoagulation for diabetic macular edema
Authors: Jiang Li, Luo Xiaoling, Qin Bo, Deng Tingming, Yang Mingming DOI: 10.3760/cma.j.cn115989-20201104-00746 Published 2022-01-10 Cite asChin J Exp Ophthalmol, 2022, 40(1): 41-46. Abstract [View PDF] [Read Full Text] Objective To compare the clinical efficiency and safety between intravitreal injection of conbercept […]
Safety of intravitreal injection of recombinant human endostatin in rabbits
Authors: Xia Ying, Chen Fang, Du Wei, Zhu Jun, Jia Shuya, Ma Haiying, Xie Zhenggao DOI: 10.3760/cma.j.cn115989-20201104-00744 Published 2021-01-10 Cite as Chin J Exp Ophthalmol, 2021,39(01): 1-6. Abstract [View PDF] [Read Full Text] Objective […]
A comparative study on conbercept and triamcinolone acetoinde intravitreal injection for macular edema secondary to central retinal vein occlusion
Authors: Ma Fengwei, Du Cuiyun, Cheng Meihong, Ma Yusheng DOI: 10.3760/cma.j.issn.2095-0160.2016.09.013 Published 2016-09-10 Cite as Chin J Exp Ophthalmol, 2016,34(9): 837-841. Abstract [Download PDF] [Read Full Text] Background Macular edema is one of the serious complications of central retinal vein occlusion (CRVO), and the present therapies are laser coagulation […]
Therapeutic efficacy and significance of intravitreal injection of ranibizumab for age-related macular degeneration with subfoveal scarring and active lesion
Authors: Li Juanjuan, Li Hua DOI: 10.3760/cma.j.issn.2095-0160.2017.01.009 Published 2017-01-10 Cite as Chin J Exp Ophthalmol, 2017,35(1): 42-46. Abstract [Download PDF] [Read Full Text] Background Intravitreal injection of ranibizumab is a primary approach to the treatment of wet age-related macular degeneration (wAMD), but whether it is necessary for […]